Investors

SEC Filings

SEC Filings

Filing date	Form	Description	Filing Group	View
November 22, 2023	SC 13D/A	An amendment to a SC 13D filing	Other	0001104659-23-120754.rtf View HTML 0001104659-23-120754.pdf 0001104659-23-120754.xls
August 21, 2023	15-12G	15-12G	Other	0001193125-23-216824.rtf View HTML 0001193125-23-216824.pdf 0001193125-23-216824.xls
August 16, 2023	EFFECT	EFFECT	Other	9999999995-23-002403.rtf View HTML 9999999995-23-002403.pdf 9999999995-23-002403.xls
August 11, 2023	25-NSE	25-NSE	Other	0001354457-23-000573.rtf View HTML 0001354457-23-000573.pdf 0001354457-23-000573.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045412.rtf View HTML 0001209191-23-045412.pdf 0001209191-23-045412.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045411.rtf View HTML 0001209191-23-045411.pdf 0001209191-23-045411.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045414.rtf View HTML 0001209191-23-045414.pdf 0001209191-23-045414.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045417.rtf View HTML 0001209191-23-045417.pdf 0001209191-23-045417.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045415.rtf View HTML 0001209191-23-045415.pdf 0001209191-23-045415.xls
August 11, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001209191-23-045428.rtf View HTML 0001209191-23-045428.pdf 0001209191-23-045428.xls

Data provided by Kaleidoscope.

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com

Email Alerts

Required fields denoted by an asterisk ().

Alert type
SEC Alert
Calendar Alert
News Alert
Report Alert

Click here to unsubscribe from email alerts

© 2024 Chinook Therapeutics, Inc.. All rights reserved

Website Design: Hane Chow, Inc.